UK markets closed
NIKKEI 225
39,667.07 +493.92 (+1.26%) HANG SENG
18,089.93 +17.03 (+0.09%) CRUDE OIL
80.82 -0.01 (-0.01%) GOLD FUTURES
2,310.60 -20.20 (-0.87%) DOW
39,162.71 +50.55 (+0.13%) Bitcoin GBP
48,235.19 -1,022.13 (-2.08%)
ESSA Pharma Inc. (EPIX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:39PM EDT. Market open.
| Previous close | 4.8500 |
| Open | 4.7500 |
| Bid | 4.7300 x 100 |
| Ask | 5.0900 x 100 |
| Day's range | 4.6767 - 4.8499 |
| 52-week range | 2.5800 - 11.6700 |
| Volume | |
| Avg. volume | 62,800 |
| Market cap | 213.608M |
| Beta (5Y monthly) | 1.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6300 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.00 |
PR NewswireESSA Pharma to Present at the Jefferies Global Healthcare Conference
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 p.m. ET in New York.
Simply Wall St.Insider Stock Buying Reaches US$709.0k On ESSA Pharma
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
PR NewswireESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2024.
© 2024 Yahoo. All rights reserved.